| http://www.w3.org/ns/prov#value | - Agent: Osi Pharmaceuticals, Inc.20100173890 - Compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity a: The present invention relates to new compounds of formula I, or salts, solvates or solvated salts
|
